S&P 500   5,130.80 (-0.12%)
DOW   38,980.11 (-0.27%)
QQQ   445.22 (-0.09%)
AAPL   175.28 (-2.44%)
MSFT   415.51 (+0.00%)
META   499.65 (-0.53%)
GOOGL   133.71 (-2.50%)
AMZN   178.15 (-0.04%)
TSLA   189.13 (-6.67%)
NVDA   864.46 (+5.06%)
NIO   5.43 (-6.06%)
AMD   208.48 (+2.88%)
BABA   72.07 (-3.42%)
T   16.77 (-1.24%)
F   12.81 (+2.89%)
MU   96.73 (+1.66%)
CGC   3.05 (-4.98%)
GE   160.91 (+1.42%)
DIS   113.97 (+1.80%)
AMC   4.34 (-0.46%)
PFE   25.80 (-2.97%)
PYPL   60.12 (-0.69%)
XOM   104.43 (-1.33%)
S&P 500   5,130.80 (-0.12%)
DOW   38,980.11 (-0.27%)
QQQ   445.22 (-0.09%)
AAPL   175.28 (-2.44%)
MSFT   415.51 (+0.00%)
META   499.65 (-0.53%)
GOOGL   133.71 (-2.50%)
AMZN   178.15 (-0.04%)
TSLA   189.13 (-6.67%)
NVDA   864.46 (+5.06%)
NIO   5.43 (-6.06%)
AMD   208.48 (+2.88%)
BABA   72.07 (-3.42%)
T   16.77 (-1.24%)
F   12.81 (+2.89%)
MU   96.73 (+1.66%)
CGC   3.05 (-4.98%)
GE   160.91 (+1.42%)
DIS   113.97 (+1.80%)
AMC   4.34 (-0.46%)
PFE   25.80 (-2.97%)
PYPL   60.12 (-0.69%)
XOM   104.43 (-1.33%)
S&P 500   5,130.80 (-0.12%)
DOW   38,980.11 (-0.27%)
QQQ   445.22 (-0.09%)
AAPL   175.28 (-2.44%)
MSFT   415.51 (+0.00%)
META   499.65 (-0.53%)
GOOGL   133.71 (-2.50%)
AMZN   178.15 (-0.04%)
TSLA   189.13 (-6.67%)
NVDA   864.46 (+5.06%)
NIO   5.43 (-6.06%)
AMD   208.48 (+2.88%)
BABA   72.07 (-3.42%)
T   16.77 (-1.24%)
F   12.81 (+2.89%)
MU   96.73 (+1.66%)
CGC   3.05 (-4.98%)
GE   160.91 (+1.42%)
DIS   113.97 (+1.80%)
AMC   4.34 (-0.46%)
PFE   25.80 (-2.97%)
PYPL   60.12 (-0.69%)
XOM   104.43 (-1.33%)
S&P 500   5,130.80 (-0.12%)
DOW   38,980.11 (-0.27%)
QQQ   445.22 (-0.09%)
AAPL   175.28 (-2.44%)
MSFT   415.51 (+0.00%)
META   499.65 (-0.53%)
GOOGL   133.71 (-2.50%)
AMZN   178.15 (-0.04%)
TSLA   189.13 (-6.67%)
NVDA   864.46 (+5.06%)
NIO   5.43 (-6.06%)
AMD   208.48 (+2.88%)
BABA   72.07 (-3.42%)
T   16.77 (-1.24%)
F   12.81 (+2.89%)
MU   96.73 (+1.66%)
CGC   3.05 (-4.98%)
GE   160.91 (+1.42%)
DIS   113.97 (+1.80%)
AMC   4.34 (-0.46%)
PFE   25.80 (-2.97%)
PYPL   60.12 (-0.69%)
XOM   104.43 (-1.33%)
NASDAQ:JYNT

Joint (JYNT) Stock Price, News & Analysis

$9.26
-0.63 (-6.37%)
(As of 03:44 PM ET)
Today's Range
$9.22
$10.03
50-Day Range
$8.97
$10.95
52-Week Range
$7.31
$19.40
Volume
135,623 shs
Average Volume
79,367 shs
Market Capitalization
$136.59 million
P/E Ratio
71.24
Dividend Yield
N/A
Price Target
$21.00

Joint MarketRank™ Stock Analysis

Analyst Rating
Hold
2.25 Rating Score
Upside/​Downside
126.8% Upside
$21.00 Price Target
Short Interest
Bearish
6.63% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.63mentions of Joint in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
100.00%
From $0.12 to $0.24 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.56 out of 5 stars

Medical Sector

526th out of 948 stocks

Patent Owners & Lessors Industry

3rd out of 6 stocks


JYNT stock logo

About Joint Stock (NASDAQ:JYNT)

The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

JYNT Stock Price History

JYNT Stock News Headlines

Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Best joint personal loans of February 2024
Joint (JYNT) to Release Quarterly Earnings on Thursday
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
The Joint Corp (JYNT)
The Joint Corp. Reports 2023 Operating Metrics
How to Get a Joint Personal Loan
Best joint checking accounts of January 2024
Returns Are Gaining Momentum At Joint (NASDAQ:JYNT)
The Joint Corp JYNT
The Joint Chiropractic Announces its "Back Friday" Deal
See More Headlines
Receive JYNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Joint and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
9/13/2023
Today
3/04/2024
Next Earnings (Confirmed)
3/07/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Patent owners & lessors
Sub-Industry
N/A
Current Symbol
NASDAQ:JYNT
Employees
359
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$21.00
High Stock Price Target
$30.00
Low Stock Price Target
$13.00
Potential Upside/Downside
+126.8%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
4 Analysts

Profitability

Net Income
$630,000.00
Pretax Margin
2.76%

Debt

Sales & Book Value

Annual Sales
$101.91 million
Cash Flow
$0.50 per share
Book Value
$2.24 per share

Miscellaneous

Free Float
14,164,000
Market Cap
$136.59 million
Optionable
Optionable
Beta
1.57
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. Peter D. Holt (Age 65)
    CEO, President & Director
    Comp: $469.55k
  • Jake SingletonJake Singleton (Age 42)
    Chief Financial Officer
    Comp: $280.92k
  • Mr. Jorge Armenteros
    Senior Vice President of Operations
  • Mr. Charles Nelles
    Chief Technology Officer
  • Dr. Steven Knauf
    Vice President of Chiropractic & Compliance
  • Ms. Lori I. Abou Habib (Age 44)
    Chief Marketing Officer
  • Ms. Krischelle Tennessen
    Chief Human Resources Officer
  • Mr. Eric Simon
    Senior VP of Franchise Sales & Development
  • Mr. Craig P. Colmar J.D. (Age 71)
    Secretary
    Comp: $37k














JYNT Stock Analysis - Frequently Asked Questions

Should I buy or sell Joint stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Joint in the last twelve months. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" JYNT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in JYNT, but not buy additional shares or sell existing shares.
View JYNT analyst ratings
or view top-rated stocks.

What is Joint's stock price target for 2024?

4 equities research analysts have issued 1-year target prices for Joint's stock. Their JYNT share price targets range from $13.00 to $30.00. On average, they expect the company's share price to reach $21.00 in the next year. This suggests a possible upside of 126.8% from the stock's current price.
View analysts price targets for JYNT
or view top-rated stocks among Wall Street analysts.

How have JYNT shares performed in 2024?

Joint's stock was trading at $9.61 at the start of the year. Since then, JYNT stock has decreased by 3.6% and is now trading at $9.26.
View the best growth stocks for 2024 here
.

When is Joint's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 7th 2024.
View our JYNT earnings forecast
.

How can I listen to Joint's earnings call?

Joint will be holding an earnings conference call on Thursday, March 7th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-0088 with passcode "5448318".

How were Joint's earnings last quarter?

The Joint Corp. (NASDAQ:JYNT) announced its quarterly earnings results on Wednesday, September, 13th. The company reported ($0.01) earnings per share for the quarter, missing analysts' consensus estimates of $0.01 by $0.02. The business had revenue of $29.31 million for the quarter, compared to the consensus estimate of $29.85 million. Joint had a net margin of 1.69% and a trailing twelve-month return on equity of 5.60%.

What is Peter D. Holt's approval rating as Joint's CEO?

87 employees have rated Joint Chief Executive Officer Peter D. Holt on Glassdoor.com. Peter D. Holt has an approval rating of 59% among the company's employees. This puts Peter D. Holt in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Joint own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Joint investors own include Advanced Micro Devices (AMD), RTX (RTX), Salesforce (CRM), Mastercard (MA), Starbucks (SBUX), Twitter (TWTR), Viking Therapeutics (VKTX), AbbVie (ABBV) and Adobe (ADBE).

When did Joint IPO?

(JYNT) raised $20 million in an IPO on Tuesday, November 11th 2014. The company issued 3,000,000 shares at a price of $6.50 per share. Roth Capital Partners and Feltl and Company acted as the underwriters for the IPO and Sanders Morris Harris was co-manager.

Who are Joint's major shareholders?

Joint's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (6.99%), Skylands Capital LLC (4.09%), Dimensional Fund Advisors LP (1.21%), Northern Trust Corp (0.92%), Russell Investments Group Ltd. (0.56%) and Trexquant Investment LP (0.56%). Insiders that own company stock include Bandera Partners Llc, Glenn J Krevlin, Jake Singleton, James H Amos Jr, Matthew E Rubel, Matthew E Rubel, Peter D Holt and Ronald V Davella.
View institutional ownership trends
.

How do I buy shares of Joint?

Shares of JYNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:JYNT) was last updated on 3/4/2024 by MarketBeat.com Staff